Literature DB >> 7613635

Statistical models for cancer screening.

C E Stevenson1.   

Abstract

This paper reviews the application of statistical models to planning and evaluating cancer screening programmes. Models used to analyse screening strategies can be classified as either surface models, which consider only those events which can be directly observed such as disease incidence, prevalence or mortality, or deep models, which incorporate hypotheses about the disease process that generates the observed events. This paper focuses on the latter type. These can be further classified as analytic models, which use a model of the disease to derive direct estimates of characteristics of the screening procedure and its consequent benefits, and simulation models, which use the disease model to simulate the course of the disease in a hypothetical population with and without screening and derive measures of the benefit of screening from the simulation outcomes. The main approaches to each type of model are described and an overview given of their historical development and strengths and weaknesses. A brief review of fitting and validating such models is given and finally a discussion of the current state of, and likely future trends in, cancer screening models is presented.

Entities:  

Mesh:

Year:  1995        PMID: 7613635     DOI: 10.1177/096228029500400103

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  5 in total

1.  Modeling all-cause mortality: projections of the impact of smoking cessation based on the NHEFS. NHANES I Epidemiologic Follow-up Study.

Authors:  L B Russell; J L Carson; W C Taylor; E Milan; A Dey; R Jagannathan
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

2.  Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.

Authors:  Elliot Lee; Mariel S Lavieri; Michael L Volk; Yongcai Xu
Journal:  Health Care Manag Sci       Date:  2014-10-12

3.  Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening.

Authors:  Stuart G Baker; Diane Erwin; Barnett S Kramer; Philip C Prorok
Journal:  BMC Med Res Methodol       Date:  2003-03-06       Impact factor: 4.615

4.  Screening For Colorectal Cancer in the Age of Simulation Models: A Historical Lens.

Authors:  Christopher J Phillips; Robert E Schoen
Journal:  Gastroenterology       Date:  2020-07-16       Impact factor: 22.682

5.  Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review.

Authors:  Sandra M E Geurts; Anne M W M Aarts; André L M Verbeek; Tony H H Chen; Mireille J M Broeders; Stephen W Duffy
Journal:  Epidemiol Health       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.